找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Advances in Diagnosis and Management of Ovarian Cancer; Samir A. Farghaly Book 2022Latest edition Springer Nature Switzerland AG 2022 Canc

[復(fù)制鏈接]
樓主: 遮陽傘
11#
發(fā)表于 2025-3-23 13:28:19 | 只看該作者
12#
發(fā)表于 2025-3-23 17:41:34 | 只看該作者
The Epidemiology of Vascular Dementiaerapy (EPIC) with paclitaxel is appropriate. Knowledge of the pharmacology of intraperitoneal chemotherapy agents is essential for selecting the proper drugs for use as HIPEC or EPIC. At the time of cytoreductive surgery with HIPEC, an intraperitoneal port is placed for subsequent combined bidirecti
13#
發(fā)表于 2025-3-23 20:18:50 | 只看該作者
https://doi.org/10.1007/978-3-642-76208-6e patients are subsequently treated with other agents, such as liposomal doxorubicin, gemcitabine, topotecan, or etoposide. The overall response rates to these other drugs are 10–25%. The identification of the genes and their protein products in ovarian cancer that contribute to the malignant phenot
14#
發(fā)表于 2025-3-24 00:57:05 | 只看該作者
15#
發(fā)表于 2025-3-24 03:31:39 | 只看該作者
16#
發(fā)表于 2025-3-24 06:56:59 | 只看該作者
17#
發(fā)表于 2025-3-24 11:17:20 | 只看該作者
18#
發(fā)表于 2025-3-24 16:23:32 | 只看該作者
J. H. Garcia,M. L. Anderson,J. H. Halsey Jr.s diagnosed in 2012 (4% of female cases and 2% of the total)..Of the subtypes, epithelial ovarian cancer is the most common, with other cancers such as germ cell or granulosa cell tumours occurring less frequently. High-grade serous is the most common epithelial ovarian cancer subtype..Ovarian cance
19#
發(fā)表于 2025-3-24 20:39:39 | 只看該作者
The Classification of Calcium Antagonistsian cancer is not associated with identifiable symptoms and screening efforts have not been able to significantly impact the mortality from this malignancy for multiple reasons. While work has been directed toward developing more sensitive tests, ovarian cancer appears to develop in the fallopian tu
20#
發(fā)表于 2025-3-25 01:56:49 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-13 08:10
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
共和县| 高邑县| 介休市| 忻城县| 萍乡市| 吉隆县| 迁安市| 内丘县| 江阴市| 库伦旗| 昌江| 江油市| 界首市| 龙胜| 兴安县| 苍南县| 东城区| 广东省| 都安| 泽普县| 大城县| 新乡县| 通州区| 固阳县| 文昌市| 沾益县| 龙井市| 西畴县| 新昌县| 大渡口区| 黑龙江省| 天等县| 比如县| 太白县| 简阳市| 丰城市| 巴林右旗| 新沂市| 玛曲县| 苏尼特左旗| 许昌市|